Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

February 2010

Dental News Roundup February 2010 BY LAUREN UZDIENSKI, FEBRUARY 26, 2010

biohorizons_product.jpgDentsply reported 4Q:09 sales of $568.7 million, up 12% over the year-ago period and beating estimates by $12.0 million. Chairman and CEO Bret Wise commented, "We are pleased to report stronger sales and earnings for the fourth quarter, as we are beginning to see the initial signs of recovery in select markets and regions." more

Musculoskeletal News Roundup 25-Feb-10 BY LAUREN UZDIENSKI, FEBRUARY 25, 2010

xray_small.jpgAlphatec Spine reported 4Q:09 revenues of $36.6 million, an increase of 29% from the $28.4 million reported in 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. U.S. revenues for the quarter were $28.3 million, an increase of 29% from the $22.0 million reported for 4Q:08. Asian revenues were $6.6 million, an increase of 38% from the $4.8 million reported for 4Q:08. European revenues in 4Q:09 were $1.7 million. more

Alphatec Spine Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Scient'x Groupe S.A.S. BY EDITOR, FEBRUARY 25, 2010

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine,... more

Nobel Biocare Announces Partnership with Noritake BY LAUREN UZDIENSKI, FEBRUARY 25, 2010

On Tuesday Nobel Biocare announced that it would expand its Preferred Partner Program to include Noritake Dental Supply. The company says the partnership "enables Nobel Biocare to offer superior end-to-end prosthetic solutions." Based in Nagoya, Japan, Noritake Dental specializes in... more

TKA Patients Gain More Weight Post-Op Compared to Healthy Controls BY LAUREN UZDIENSKI, FEBRUARY 23, 2010

Despite the increased mobility associated with total knee replacement, a new study found that TKA patients actually gain more weight post-operatively than non-surgical controls. The study, published in Osteoarthritis and Cartilage, enrolled 106 TKA patients and 31 non-surgical controls. The... more

President Obama Unveils Plan for Healthcare Reform BY LAUREN UZDIENSKI, FEBRUARY 22, 2010

This morning President Obama announced his plan for reforming healthcare. The proposal is similar to the legislation the Senate passed late last year, though it includes some concessions to the House, and the president describes it as "[bridging] the gap"... more

Industry and Public Weigh in on 510(k) Process BY LAUREN UZDIENSKI, FEBRUARY 19, 2010

Yesterday the FDA hosted an all-day public hearing to gain feedback on its 510(k) process, looking specifically at issues of predicate devices, new technologies, submission volume and post-market surveillance. The event was webcast and opened to a packed house -... more

Musculoskeletal News Roundup 18-Feb-10 BY LAUREN UZDIENSKI, FEBRUARY 18, 2010

Earnings DJO reported 4Q:09 revenues of $257.2 million, up 5% over 4Q:08, with domestic rehab sales up 3% and domestic surgical implant sales up 8%. The company attributed the latter largely to "strong sales of our Reverse Shoulder Prosthesis." Net... more

Blue Cross and Blue Shield Names Spine, Large Joint Centers to its Blue Distinction Program BY LAUREN UZDIENSKI, FEBRUARY 16, 2010

Blue Cross and Blue Shield announced that they would broaden their "Blue Distinction" designation granted to high-performing hospitals to include spine and hip and knee centers. Blue Distinction hospitals have met objective, "evidence-based thresholds for clinical quality and safety" and... more

FDA Approves Xiaflex as the First Non-Surgical Treatment for Dupuytren's Contracture BY LAUREN UZDIENSKI, FEBRUARY 11, 2010

The FDA approved a BLA for Auxilium's Xiaflex (collagenase clostridium histolyticum) last week, following a unanimous panel recommendation (registration required) in September. Xiaflex is the first non-surgical treatment for Dupuytren's Contracture, which is characterized by a bending of the fingers... more

Musculoskeletal News Roundup 11-Feb-10 BY LAUREN UZDIENSKI, FEBRUARY 11, 2010

Earnings Nobel Biocare reported 4Q:09 revenues of EUR 156.0 million ($213.6 million), flat over the year-ago period and missing estimates by EUR 5.0 million ($6.9 million.) EPS of EUR 0.21 ($0.29) missed estimates by EUR 0.05 ($0.07). The company called... more

FDA to Fund Device Registry in 2011 BY LAUREN UZDIENSKI, FEBRUARY 9, 2010

As outlined in President Obama's proposed budget for the 2011 fiscal year, the FDA has increased their operating budget for the upcoming year by about 23% to $4 billion. The agency has said the bulk of the increase will be... more

Orthopedics in China and the U.S.: An Interview with HealthpointCapital's Chinese Research Scholar BY JOHN MCCORMICK, FEBRUARY 8, 2010

Starting in October 2009, HealthpointCapital initiated a one-year Research Scholarship at the Hospital for Special Surgery (HSS) for a select oprthopedic surgeon from China. This month, we checked in with our Research Scholar, Dr. Xiaodong Ju, to see how he... more

Musculoskeletal News Roundup 4-Feb-10 BY LAUREN UZDIENSKI, FEBRUARY 4, 2010

Earnings CONMED reported 4Q:09 sales of $190.6 million, up 3% over the year-ago period and beating estimates by $6.0 million. Arthroscopy sales rose 3% to $75.7 million. All growth rates exclude the effects of currency. 4Q:09 EPS of $0.37 beat... more

510(k) Under Review at the FDA BY LAUREN UZDIENSKI, FEBRUARY 3, 2010

Despite some prior indications that the 510(k) process would remain as-is for now, it seems 510(k) reform is now taking a prominent spot on the FDA's agenda for 2010, with one report saying "revisions" to the pathway should be in... more

Alphatec Spine Receives CE Mark for its OsseoScrew Spinal Fixation System and Its GLIF/ ARC Portal Access System BY EDITOR, FEBRUARY 2, 2010

Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine,... more

NuVasive Pre-Announces 4Q, Beating Estimates BY LAUREN UZDIENSKI, FEBRUARY 1, 2010

Last Friday, NuVasive pre-announced full-year 2009 revenues of $370 million, increasing about 48% over 2008, and EPS of $0.14-$0.15. Analysts had forecast sales of $367 million and EPS of $0.14, setting the company up for a modest top-line beat. President... more


Complete Archive